72 results
6-K
EX-99.1
ARGX
Argen X SE
16 Apr 24
ADHERE data show VYVGART® Hytrulo has potential to be first advancement for CIDP patients in 30 years
6:05am
was confirmed by an independent panel of experts. Patients entered a run-in stage, where any ongoing CIDP treatment was stopped and in order to be eligible
6-K
EX-99.1
t0qtp
21 Mar 24
Current report (foreign)
6:07am
6-K
EX-99.2
c82r8oepzers47
29 Feb 24
Current report (foreign)
4:04pm
6-K
EX-99.2
d8riao m6wp
8 Jan 24
Reported $1.2 billion in preliminary* full-year 2023 global net product sales
6:06am
6-K
EX-99.2
2l4n7of5zedtb hgrycb
31 Oct 23
Current report (foreign)
9:14am
S-8
EX-23.1
lff5e3 qurc
27 Sep 23
Registration of securities for employees
4:42pm
6-K
EX-99.1
hqd80p
27 Jul 23
Current report (foreign)
6:02am
6-K
dvjonq3 3c
20 Jul 23
Current report (foreign)
5:44pm
6-K
EX-1.1
zee1b c0x
20 Jul 23
Current report (foreign)
5:44pm
424B5
km2gb8
20 Jul 23
Prospectus supplement for primary offering
4:51pm
424B5
p2ook7q
17 Jul 23
Prospectus supplement for primary offering
4:42pm
6-K
EX-99.2
40zzhu0 810yswxw9q
17 Jul 23
Current report (foreign)
7:56am
6-K
EX-99.1
65ohpp
17 Jul 23
Current report (foreign)
7:56am
6-K
EX-99.3
453uxhsv 9v
21 Jun 23
Current report (foreign)
8:52am
6-K
EX-99.1
dmop3o6ja3s8r 73
21 Jun 23
Current report (foreign)
8:52am
6-K
EX-99.2
6u70xw k3nk
5 May 23
Current report (foreign)
8:05am